Patients with mild Alzheimer’s disease over age 65 continue to derive benefit from DBS-f treatment

June 19, 2018 GOSCIN 0Comments

An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most benefit from Deep Brain Stimulation of the fornix, as observed in the data from the phase 2 findings (12 – 24 months) of the Phase II trial.

from News-Medical.Net Spinal Cord Injury News Feed https://ift.tt/2tn7TnI
via Medical.news

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.